Horizon Pharma Expands U.S. Headquarters with Opening of Chicago Office
News Feb 24, 2015
Horizon Pharma plc has announced that it has opened a Chicago office.
The office, which is located at 150 South Wacker Drive, will primarily house commercial, corporate analytics and business development staff.
"More than twenty-five percent of our Illinois employees live in the City of Chicago and we felt it was important to establish a city presence in order to assist our employees in maximizing their personal and professional potential," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma, plc. "As one of the fastest growing biopharmaceutical companies in Illinois, a city presence offers access to top talent and easier access to the growing biotech and biopharma community."
"I am pleased that Horizon Pharma recognizes the thriving healthcare economy in Chicago and is making this investment in the city," said Mayor Rahm Emanuel. "Chicago's diverse and deep pool of talent remains a significant driver in companies like this making the decision to locate here."
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Key to Creating Better Medicines with Less Side EffectsNews
A new study published in Science by Professors Yossi Paltiel of the Hebrew University of Jerusalem and Ron Naaman from the Weizmann Institute of Science describes a breakthrough technology with the power to create drugs with fewer unwanted side effects.
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018